[go: up one dir, main page]

NO952336D0 - Insulin analoger - Google Patents

Insulin analoger

Info

Publication number
NO952336D0
NO952336D0 NO952336A NO952336A NO952336D0 NO 952336 D0 NO952336 D0 NO 952336D0 NO 952336 A NO952336 A NO 952336A NO 952336 A NO952336 A NO 952336A NO 952336 D0 NO952336 D0 NO 952336D0
Authority
NO
Norway
Prior art keywords
insulin analogues
analogues
insulin
Prior art date
Application number
NO952336A
Other languages
English (en)
Other versions
NO952336L (no
Inventor
Ronald Eugene Chance
Li Fan
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO952336D0 publication Critical patent/NO952336D0/no
Publication of NO952336L publication Critical patent/NO952336L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Emergency Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO952336A 1992-12-18 1995-06-13 Insulin analoger NO952336L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US99565992A 1992-12-18 1992-12-18
PCT/US1993/012237 WO1994014461A1 (en) 1992-12-18 1993-12-15 Insulin analogs

Publications (2)

Publication Number Publication Date
NO952336D0 true NO952336D0 (no) 1995-06-13
NO952336L NO952336L (no) 1995-06-13

Family

ID=25542078

Family Applications (1)

Application Number Title Priority Date Filing Date
NO952336A NO952336L (no) 1992-12-18 1995-06-13 Insulin analoger

Country Status (14)

Country Link
EP (1) EP0605983A3 (no)
JP (1) JPH08504820A (no)
CN (1) CN1094059A (no)
AU (1) AU680462B2 (no)
BR (1) BR9307687A (no)
CA (1) CA2151134A1 (no)
CZ (1) CZ158895A3 (no)
FI (1) FI953001L (no)
HU (1) HUT71583A (no)
MX (1) MX9307991A (no)
NO (1) NO952336L (no)
PL (1) PL310007A1 (no)
WO (1) WO1994014461A1 (no)
ZA (1) ZA939477B (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5559094A (en) * 1994-08-02 1996-09-24 Eli Lilly And Company AspB1 insulin analogs
CN1125081C (zh) * 1999-09-08 2003-10-22 中国科学院上海生物化学研究所 重组天然和新型人胰岛素及其制备方法
DE10114178A1 (de) 2001-03-23 2002-10-10 Aventis Pharma Gmbh Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
DE10227232A1 (de) 2002-06-18 2004-01-15 Aventis Pharma Deutschland Gmbh Saure Insulinzubereitungen mit verbesserter Stabilität
PT2349324T (pt) 2008-10-17 2017-12-06 Sanofi Aventis Deutschland Combinação de uma insulina e de um agonista do glp-1
WO2011058083A1 (de) 2009-11-13 2011-05-19 Sanofi-Aventis Deutschland Gmbh Pharmazeutische zusammensetzung umfassend einen glp-1-agonisten, ein insulin und methionin
SG10201500871TA (en) 2009-11-13 2015-04-29 Sanofi Aventis Deutschland Pharmaceutical composition comprising a glp-1 agonist and methionine
RS55378B1 (sr) 2010-08-30 2017-03-31 Sanofi Aventis Deutschland Upotreba ave0010 za proizvodnju leka za tretman diabetes mellitus tipa 2
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
HRP20151068T1 (hr) 2011-08-29 2016-01-01 Sanofi-Aventis Deutschland Gmbh Farmaceutska kombinacija za upotrebu za glikemijsku kontrolu kod pacijenata s dijabetesom tipa 2
AR087744A1 (es) 2011-09-01 2014-04-16 Sanofi Aventis Deutschland Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa
CN104981251B (zh) * 2012-09-26 2018-03-20 印第安纳大学研究及科技有限公司 胰岛素类似物二聚体
TWI758239B (zh) 2014-12-12 2022-03-21 德商賽諾菲阿凡提斯德意志有限公司 甘精胰島素/利司那肽固定比率配製劑
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患之治療

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH25772A (en) * 1985-08-30 1991-10-18 Novo Industri As Insulin analogues, process for their preparation
CA2071382A1 (en) * 1991-06-21 1992-12-22 David N. Brems Insulin analogs

Also Published As

Publication number Publication date
CN1094059A (zh) 1994-10-26
BR9307687A (pt) 2002-02-19
FI953001A0 (fi) 1995-06-16
ZA939477B (en) 1995-06-19
HUT71583A (en) 1995-12-28
JPH08504820A (ja) 1996-05-28
EP0605983A3 (en) 1995-06-07
NO952336L (no) 1995-06-13
WO1994014461A1 (en) 1994-07-07
MX9307991A (es) 1994-08-31
EP0605983A2 (en) 1994-07-13
PL310007A1 (en) 1995-11-13
AU5827994A (en) 1994-07-19
HU9501762D0 (en) 1995-08-28
CZ158895A3 (en) 1995-12-13
FI953001A7 (fi) 1995-06-16
CA2151134A1 (en) 1994-07-07
AU680462B2 (en) 1997-07-31
FI953001L (fi) 1995-06-16

Similar Documents

Publication Publication Date Title
FI952663L (fi) Ruisku
BR9305077A (pt) Seringa hipodémica
ATE237635T1 (de) Acylierte insulinanalogen
FI914898A7 (fi) Maksaspesifiset insuliinianalogit
FI955578A7 (fi) Lääkeruisku
FI952961L (fi) Dolostatiinianalogeja
DK186089A (da) Sproejter
DE69222622D1 (de) Spritze
FI925343L (fi) Tri-arginin-insuliner
BR9306974A (pt) Seringa
FI945811A7 (fi) Des-Tyr-dynorfiinianalogeja
DE59308356D1 (de) Spritze
FI943581A7 (fi) Ruisku
NO952336D0 (no) Insulin analoger
DE69309570D1 (de) Spritze
FI922882A7 (fi) Insuliinianalogeja
FI960051L (fi) Difluoristatonianalogeja
KR920021041U (ko) 세척기
FI905566A7 (fi) Insuliinin analogeja
NO950721L (no) Insulinanaloger
NO942783D0 (no) Spröyte
KR940001042U (ko) 앰플(Ampoule)
KR930017636U (ko) 세척기
SE9202756D0 (sv) Spruta
BR9200932A (pt) Seringa